Moreover, no single HHHS patient has so far developed HCC or systemic diseases that, in heterozygous AATD patients, are associated with serum elevation of AAT due to the “R-SB” phenomenon. This evidence concerns the gene SERPINA1 and ornithine translocase deficiency.